Press Release Feb 24 2026
Filed with NSE · · 3 pages · English
In the deck
Earlier from Biocon
- Press Release Feb 12 2026
- Press Release Feb 07 2026
- Press Release Jan 28 2026
- Press Release Jan 15 2026
- Press Release Jan 06 2026
Later from Biocon
- Press Release Mar 27 2026
- Shreehas Tambe Appointed CEO and Managing Director of Biocon Limited, Effective April 1, 2026
- Press Release Apr 07 2026
- Biocon Limited Press Release Apr 21 2026
- Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia® and Xgeva®
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon